Morgane Denis Selected Research

Immunologic Adjuvants (Immunologic Adjuvant)

1/2023

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Morgane Denis Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 01/2018
1	Fanconi Anemia (Fanconi's Anemia) 04/2024
1	Inflammation (Inflammations) 03/2024
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 03/2024
1	Lymphoma (Lymphomas) 01/2023
1	Dehydration (Water Stress) 06/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Multiple Myeloma 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2022

Drug/Important Bio-Agent (IBA)

2	Immune Checkpoint InhibitorsIBA 01/2020 - 01/2018
1	Monoclonal AntibodiesIBA 04/2024
1	Peptides (Polypeptides)IBA 03/2024
1	HydrogelsIBA 03/2024
1	Rituximab (Mabthera)FDA Link 01/2023
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	LipopolysaccharidesIBA 01/2023
1	Liposomes (Liposome)IBA 01/2023
1	Toll-Like Receptor 4IBA 01/2023
1	PowdersIBA 06/2022
1	CationsIBA 06/2022
1	IronIBA 06/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	AntibodiesIBA 01/2022
1	Netrin-1IBA 01/2022
1	NetrinsIBA 01/2022
1	LigandsIBA 01/2022

Therapy/Procedure

4	Therapeutics 03/2024 - 01/2022
2	Aftercare (After-Treatment) 01/2022 - 01/2018
1	Oral Administration 03/2024
1	Intravenous Administration 01/2023
1	Replantation 01/2022
1	Immunotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2018